Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 May;13(3):154-9.
doi: 10.1097/00001622-200105000-00004.

Treatment Controversies in Medulloblastoma


Treatment Controversies in Medulloblastoma

M Chintagumpala et al. Curr Opin Oncol. .

Erratum in

  • Curr Opin Oncol 2001 Sep;13(5):413


Medulloblastoma, the most common primary malignant brain tumor in children, is a radiosensitive and chemosensitive tumor. Nevertheless, medulloblastoma remains a management challenge for the clinical oncologist, because the optimal sequence and dosage for each treatment modality has not yet been defined. In addition, effective management strategies for medulloblastoma may result in profound neuroendocrine and neuropsychologic sequelae. In this article, we review the clinical and biologic prognostic factors for classifying medulloblastoma, current strategies for the management of this disease, and potential strategies to prevent or minimize long-term treatment sequelae.

Similar articles

See all similar articles

Cited by 4 articles

LinkOut - more resources